[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]

Eksp Klin Gastroenterol. 2003:(4):36-9, 114.
[Article in Russian]

Abstract

The purpose of the research was to study the efficacy of the bougienage of after-burn esophageal strictures against the background of long-term treatment with proton pump inhibitors of H2-blockers. 100 patients with after-burn esophageal strictures were divided into 3 groups in a random way: 1) only bougienage--53 patients; 2) bougienage and omeprazole, 20 mg per day during 12 months--20 patients; 3) bougienage and ranitidine, 300 mg per day during 12 months--27 patients. Bougienage was efficient in 83 patients (83%). 17 patients underwent esophagoplasty due to inefficiency of bougienage. Repeated bougienage was necessary for 35% of patients who were taking omeprazole (p = 0.04), 48.1%--ranitidine (p = 0.2), and 60.4% of patients who underwent only bougienage. Bougienage of the esophagus is efficient in treatment of after-burn strictures. Twelve-month treatment of these patients with omeprazole reduces the number of repeated bougienage courses significantly.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anti-Ulcer Agents / therapeutic use
  • Burns, Chemical / complications
  • Burns, Chemical / therapy*
  • Esophageal Stenosis / chemically induced
  • Esophageal Stenosis / prevention & control*
  • Esophageal Stenosis / therapy
  • Esophagoscopy
  • Esophagus / injuries*
  • Esophagus / surgery
  • Female
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Omeprazole / therapeutic use
  • Proton Pumps / therapeutic use
  • Ranitidine / therapeutic use
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Ulcer Agents
  • Histamine H2 Antagonists
  • Proton Pumps
  • Ranitidine
  • Omeprazole